Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) CEO Sells $64,726.14 in Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) CEO Bobak R. Azamian sold 4,278 shares of the stock in a transaction dated Friday, April 28th. The stock was sold at an average price of $15.13, for a total transaction of $64,726.14. Following the transaction, the chief executive officer now directly owns 1,065,947 shares of the company’s […]

Related Keywords

Bobakr Azamian , ,News Ratings For Tarsus Pharmaceuticals Daily ,Vanguard Group Inc ,Blackrock Inc ,Institutional Trading Of Tarsus Pharmaceuticals ,Tarsus Pharmaceuticals Inc ,Macquarie Group Ltd ,Tarsus Pharmaceuticals Stock Down ,Quarter For Tarsus Pharmaceuticals ,Tarsus Pharmaceuticals ,Jefferies Financial Group Inc ,Nasdaq ,Securities Exchange Commission ,Get Rating ,Exchange Commission ,Pharmaceuticals Stock Down ,Financial Group ,Street Corp ,Tarsus Pharmaceuticals Daily ,Nasdaq Tars ,Stars ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,